OBJECTIVES: This study aimed to clarify the dynamic changes of exhaustion features in T cells during oral carcinogenesis. MATERIALS AND METHODS: Mice were randomly divided into 4NQO group and control group. The exhaustion features of CD4(+) and CD8(+) T cells of both groups were detected by flow cytometry. Furthermore, multiplex immunohistochemistry was used to evaluate the expression of inhibitory receptors in human normal, dysplastic, and carcinogenesis tissues. Finally, anti-PD-1 antibody treatment was performed at the early premalignant phase of oral carcinogenesis. RESULTS: The proportion of naive T cells in 4NQO group was lower than those in control group, while the proportion of effector memory T cells was higher in 4NQO group. The expression of inhibitory receptors on CD4(+) and CD8(+) T cells increased gradually during carcinogenesis. In contrast, the secretion of cytokines by CD4(+) and CD8(+) T cells decreased gradually with the progression stage. Strikingly, those changes occurred before the onset of oral carcinogenesis. The expression of inhibitory receptors on T cells increased gradually as the human tissues progressed from normal, dysplasia to carcinoma. Interestingly, PD-1 blockade at the early premalignant phase could reverse carcinogenesis progression by restoring T cell function. CONCLUSIONS: T-cell dysfunction was established at the early premalignant phase of oral carcinogenesis; PD-1 blockade at the early premalignant phase can effectively reverse T-cell exhaustion features and then prevent carcinogenesis progression.
Dynamic changes of exhaustion features in T cells during oral carcinogenesis.
口腔癌发生过程中T细胞耗竭特征的动态变化
阅读:4
作者:Xie Wenqiang, Shen Jie, Wang Dikan, Guo Junyi, Li Qunxing, Wen Shuqiong, Dai Wenxiao, Wen Liling, Lu Huanzi, Fang Juan, Wang Zhi
| 期刊: | Cell Proliferation | 影响因子: | 5.600 |
| 时间: | 2022 | 起止号: | 2022 Apr;55(4):e13207 |
| doi: | 10.1111/cpr.13207 | 研究方向: | 细胞生物学 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
